13F-HR filed by Deep Track Capital, LP
Deep Track Capital, LP filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 55 holding rows worth $1,416,523,000.
- Accession
- 0001856083-22-000007
- Filer
- CIK 1856083
- Filed
- 2022-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 55 entries on the cover page, a total value of $1,416,523,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,416,521,000 with VALUE read as thousands by filing date, 13F file number 028-21949. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 1,300,000 | $76,063,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 2,450,000 | $76,048,000 | thousands by filing date | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 1,100,000 | $66,957,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 4,000,000 | $66,880,000 | thousands by filing date | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 500,000 | $63,700,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 2,000,000 | $58,540,000 | thousands by filing date | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 700,000 | $55,783,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 1,900,000 | $53,979,000 | thousands by filing date | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 2,100,000 | $44,289,000 | thousands by filing date | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 500,000 | $42,370,000 | thousands by filing date | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 1,900,000 | $41,686,000 | thousands by filing date | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 550,000 | $41,294,000 | thousands by filing date | |
| IMMUNOVANT INC | 45258J102 | COM | 4,775,000 | $40,683,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 2,420,502 | $39,478,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 2,550,000 | $35,700,000 | thousands by filing date | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 1,341,004 | $33,941,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 4,000,000 | $33,400,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 5,641,668 | $28,208,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,292,250 | $27,255,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,336,690 | $26,426,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 418,037 | $24,459,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 1,000,000 | $23,770,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 1,000,000 | $23,340,000 | thousands by filing date | call |
| GRITSTONE BIO INC | 39868T105 | COM | 1,771,801 | $22,785,000 | thousands by filing date | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 950,798 | $22,715,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 2,335,143 | $22,324,000 | thousands by filing date | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 4,870,000 | $21,574,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 500,000 | $21,270,000 | thousands by filing date | |
| PASSAGE BIO INC | 702712100 | COM | 3,216,997 | $20,428,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 1,500,000 | $19,845,000 | thousands by filing date | |
| NKARTA INC | 65487U108 | COMMON STOCK | 1,264,426 | $19,409,000 | thousands by filing date | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 500,000 | $18,435,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 130,200 | $17,056,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 400,000 | $17,016,000 | thousands by filing date | call |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 762,317 | $14,446,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 421,660 | $14,421,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 750,000 | $13,268,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U404 | CMN | 607,600 | $13,209,000 | thousands by filing date | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 1,933,040 | $13,067,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 750,000 | $11,820,000 | thousands by filing date | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 499,400 | $11,651,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 80,000 | $10,762,000 | thousands by filing date | |
| ATYR PHARMA INC | 002120202 | COM NEW | 1,100,000 | $8,217,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 500,000 | $7,845,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 500,000 | $7,845,000 | thousands by filing date | call |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 3,000,000 | $6,990,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 500,000 | $6,755,000 | thousands by filing date | put |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 400,000 | $6,672,000 | thousands by filing date | call |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 400,000 | $4,504,000 | thousands by filing date | |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 1,050,132 | $4,043,000 | thousands by filing date | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 250,000 | $3,965,000 | thousands by filing date | |
| CONNECT BIOPHARMA HLDGS LTD | 207523101 | SHS | 647,057 | $3,332,000 | thousands by filing date | |
| ONCORUS INC | 68236R103 | COM | 600,000 | $3,162,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 11,700 | $1,984,000 | thousands by filing date | put |
| Rafael Holdings Inc Class B | 75062E106 | COM | 285,714 | $1,457,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001856083-22-000007 | this filing | 2022-02-14 | acceptance time not in the bulk data set |